Health Care & Life Sciences » Biotechnology | Japan Tissue Engineering Co. Ltd.

Japan Tissue Engineering Co. Ltd. | Cash Flow

Fiscal year is April-March. All values JPY Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
823,997.00
686,687.00
677,699.00
309,951.00
213,334.00
Depreciation, Depletion & Amortization
91,032.00
89,876.00
136,044.00
112,950.00
116,197.00
Other Funds
175,965.00
54,116.00
8,228.00
3,952.00
52,441.00
Funds from Operations
908,930.00
542,695.00
549,883.00
418,950.00
277,092.00
Changes in Working Capital
52,386.00
214,030.00
202,976.00
364,000.00
354,914.00
Net Operating Cash Flow
961,316.00
756,725.00
346,907.00
54,950.00
632,006.00
Capital Expenditures
34,433.00
524,523.00
260,308.00
23,741.00
31,997.00
Purchase/Sale of Investments
340,350.00
900,000.00
2,700,000.00
-
400,000.00
Net Investing Cash Flow
306,276.00
1,425,372.00
2,959,644.00
22,242.00
429,583.00
Issuance/Reduction of Debt, Net
31,073.00
556,035.00
8,187.00
7,660.00
6,663.00
Net Financing Cash Flow
695,107.00
6,341,304.00
5,864.00
3,161.00
11,651.00
Net Change in Cash
40,067.00
4,159,207.00
3,312,415.00
35,869.00
214,074.00
Free Cash Flow
991,766.00
1,240,957.00
602,824.00
46,947.00
600,763.00
Other Sources
359.00
-
664.00
1,499.00
2,414.00
Change in Capital Stock
664,034.00
6,897,339.00
2,323.00
10,822.00
18,314.00
Other Uses
-
849.00
-
-
-

About Japan Tissue Engineering Co.

View Profile
Address
6-209-1 Miyakitadori
Gamagori Aichi 443
Japan
Employees -
Website http://www.jpte.co.jp
Updated 09/14/2018
Japan Tissue Engineering Co., Ltd. engages in the research, development, and manufacture of cultured biological cells and tissues. It operates through the Regenerative Medicine, Custom Development and Manufacturing, and Research and Development (R&D) Support segments. The Regenerative Medicine segment develops, manufactures, and sells tissue-engineered medical products through autologous culturing techniques.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.